Literature DB >> 19406273

Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]).

Stephen S Gottlieb1, Willem J Kop, Stephen J Ellis, Philip Binkley, Jonathan Howlett, Christopher O'Connor, James A Blumenthal, Gerald Fletcher, Ann M Swank, Lawton Cooper.   

Abstract

Depression is common in patients with heart failure (HF), prognostic for adverse outcomes and purportedly related to disease severity. Psychological and physiologic factors relevant to HF were assessed in HF-ACTION, a large randomized study of aerobic exercise training in patients with systolic HF. The relation of objective and subjective parameters was compared with scores on the Beck Depression Inventory (BDI) to examine the hypothesis that depressive symptoms are better associated with perception of disease severity than with objective markers of HF severity. At baseline, 2,322 of 2,331 subjects entered into HF-ACTION completed questionnaires to assess depression (BDI) and quality of life (Kansas City Cardiomyopathy Questionnaire [KCCQ]). Objective markers of HF severity included ejection fraction, B-type natriuretic peptide, and peak oxygen consumption (using cardiopulmonary exercise testing, with evaluation of duration and respiratory exchange ratio also performed). Measures more likely to be affected by perceived functional status included New York Heart Association (NYHA) classification and the 6-minute walk test. Objective assessments of disease severity were slightly related (peak oxygen consumption) or not related (B-type natriuretic peptide and ejection fraction) to BDI scores. Using multivariate analysis (KCCQ not included), only age, gender, cardiopulmonary exercise testing duration, NYHA class, 6-minute walk distance, and peak respiratory exchange ratio independently correlated with BDI scores. In conclusion, depression was minimally related to objective assessments of severity of disease in patients with HF, but was associated with patient (and clinician) perceptions of disease severity. Addressing depression might improve symptoms in patients with HF.

Entities:  

Mesh:

Year:  2009        PMID: 19406273      PMCID: PMC2695567          DOI: 10.1016/j.amjcard.2009.01.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Prevalence of depression in congestive heart failure.

Authors:  E P Havranek; M G Ware; B D Lowes
Journal:  Am J Cardiol       Date:  1999-08-01       Impact factor: 2.778

3.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

Authors:  C P Green; C B Porter; D R Bresnahan; J A Spertus
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

4.  Psychological distress and cardiovascular disease: results from the 2002 National Health Interview Survey.

Authors:  Amy K Ferketich; Philip F Binkley
Journal:  Eur Heart J       Date:  2005-06-09       Impact factor: 29.983

5.  Prognostic value of anxiety and depression in patients with chronic heart failure.

Authors:  Wei Jiang; Maragatha Kuchibhatla; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Greg L Clary; Michael A Blazing; Laura H Gaulden; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

Review 6.  Psychological factors in heart failure: a review of the literature.

Authors:  Kenneth M A MacMahon; Gregory Y H Lip
Journal:  Arch Intern Med       Date:  2002-03-11

7.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

Review 8.  High impact of depression in heart failure: early diagnosis and treatment options.

Authors:  Christine Norra; Eric C Skobel; Marlies Arndt; Patrick Schauerte
Journal:  Int J Cardiol       Date:  2007-07-26       Impact factor: 4.164

9.  The influence of age, gender, and race on the prevalence of depression in heart failure patients.

Authors:  Stephen S Gottlieb; Meenakshi Khatta; Erika Friedmann; Lynn Einbinder; Scott Katzen; Brian Baker; Joanne Marshall; Stacey Minshall; Shawn Robinson; Michael L Fisher; Matthew Potenza; Brianne Sigler; Carissa Baldwin; Sue Ann Thomas
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

10.  Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life.

Authors:  Thomas S Rector; Inder S Anand; Jay N Cohn
Journal:  J Card Fail       Date:  2006-03       Impact factor: 5.712

View more
  36 in total

1.  The health care home model: primary health care meeting public health goals.

Authors:  Roy Grant; Danielle Greene
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

3.  Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure.

Authors:  Rebecca A Gary; Sandra B Dunbar; Melinda K Higgins; Dominique L Musselman; Andrew L Smith
Journal:  J Psychosom Res       Date:  2010-03-12       Impact factor: 3.006

4.  A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality.

Authors:  Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Patricia R Houck; Fanyin He; Rene J Alvarez; Herbert C Schulberg; Charles F Reynolds; Dennis M McNamara
Journal:  J Card Fail       Date:  2011-12-22       Impact factor: 5.712

Review 5.  Psychological Aspects of Heart Failure.

Authors:  Debra K Moser; Cynthia Arslanian-Engoren; Martha J Biddle; Misook Lee Chung; Rebecca L Dekker; Muna H Hammash; Gia Mudd-Martin; Abdullah S Alhurani; Terry A Lennie
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

6.  Poor social support is associated with increases in depression but not anxiety over 2 years in heart failure outpatients.

Authors:  Erika Friedmann; Heesook Son; Sue A Thomas; Deborah W Chapa; Hyeon Joo Lee
Journal:  J Cardiovasc Nurs       Date:  2014 Jan-Feb       Impact factor: 2.083

Review 7.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

8.  Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.

Authors:  Glen L Xiong; Mona Fiuzat; Maragatha Kuchibhatla; Ranga Krishnan; Christopher M O'Connor; Wei Jiang
Journal:  Circ Heart Fail       Date:  2012-10-12       Impact factor: 8.790

9.  Depressive symptomatology, exercise adherence, and fitness are associated with reduced cognitive performance in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Aging Health       Date:  2013-01-31

10.  Potentially modifiable correlates of functional status in patients with chronic heart failure.

Authors:  Nicole Lossnitzer; Beate Wild; Jobst-Hendrik Schultz; Lutz Frankenstein; Markus Haass; Bernhard Rauch; Bernd Löwe; Hugo Katus; Wolfgang Herzog
Journal:  Int J Behav Med       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.